Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,572,924

« Back to Dashboard

Details for Patent: 7,572,924

Title:Pyrrole substituted 2-indolinone protein kinase inhibitors
Abstract: The present invention relates to pyrrole substituted-2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
Inventor(s): Tang; Peng Cho (Moraga, CA), Miller; Todd Anthony (San Marcos, CA), Li; Xiaoyuan (Los Altos, CA), Sun; Connie Li (Palo Alto, CA), Wei; Chung Chen (Foster City, CA), Shirazian; Shahrzad (Corte Madera, CA), Liang; Congxin (Jupiter, FL), Vojkovsky; Tomas (San Mateo, CA), Nematalla; Asaad S. (Concord, CA), Hawley; Michael (Kalamazoo, CA)
Assignee: Sugen, Inc. (South San Francisco, CA) Pharmacia & Upjohn Co. (Kalamazoo, MI)
Filing Date:Sep 06, 2006
Application Number:11/517,529
Claims:1. A compound of Formula (I): ##STR00212## wherein: R.sup.1 is hydrogen; R.sup.2 is halo; R.sup.3 is hydrogen; R.sup.4 is hydrogen; R.sup.5 is alkyl; R.sup.6 is --C(O)R.sup.10; R.sup.7 is alkyl; R.sup.10 is --N(R.sup.11)(CH.sub.2).sub.nR.sup.12; R.sup.11 is selected from the group consisting of hydrogen and alkyl; R.sup.12 is --NR.sup.13R.sup.14; R.sup.13 and R.sup.14 combine to form a group selected from the group consisting of --(CH.sub.2).sub.4--, --(CH.sub.2).sub.5--, --(CH.sub.2).sub.2O(CH.sub.2).sub.2--, and --(CH.sub.2).sub.2N(CH.sub.3)(CH.sub.2).sub.2--; and n is 1, 2, 3, or 4; or a pharmaceutically acceptable salt thereof.

2. A compound of formula ##STR00213## or a pharmaceutically acceptable salt thereof.

3. A pharmaceutical composition comprising the compound or salt of claim 2 and a pharmaceutically accepatable carrier or excipient.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.